Andrew McMichael

Q: What Schools Are Affiliated With Andrew McMichael

Andrew McMichael is affiliated with the following schools: University of Oxford, Stanford University, London School of Hygiene and Tropical Medicine

Andrew McMichael's AcademicInfluence.com Rankings

Andrew McMichael

Philosophy

#2004

World Rank

#3516

Historical Rank

Logic

#399

World Rank

#758

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Andrew McMichael Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Sir Andrew James McMichael, is an immunologist, Professor of Molecular Medicine, and previously Director of the Weatherall Institute of Molecular Medicine at the University of Oxford. He is particularly known for his work on T cell responses to viral infections such as influenza and HIV.

(See a Problem?)

Andrew McMichael's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Phenotypic Analysis of Antigen-Specific T Lymphocytes (1996) (3961)
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C (1998) (2125)
Ecosystems and Human well-being (2003) (1846)
The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides (1986) (1752)
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections (2002) (1736)
Common West African HLA antigens are associated with protection from severe malaria (1991) (1577)
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. (1998) (1566)
Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS (1997) (1280)
A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1 (2007) (1258)
Evolution of the immune system in humans from infancy to old age (2015) (1161)
Skewed maturation of memory HIV-specific CD8 T lymphocytes (2001) (1157)
Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition (1991) (1068)
HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function (2000) (1010)
Direct Visualization of Antigen-specific CD8+T Cells during the Primary Immune Response to Epstein-Barr Virus In Vivo (1998) (995)
Cytotoxic T-cell immunity to influenza. (1983) (933)
Bias due to misclassification in the estimation of relative risk. (1977) (905)
The immune response during acute HIV-1 infection: clues for vaccine development (2009) (884)
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19 (2020) (884)
Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans (2012) (853)
HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women (1995) (849)
Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever (2003) (815)
Alcohol, tobacco and breast cancer – collaborative reanalysis of individual data from 53 epidemiological studies, including 58 515 women with breast cancer and 95 067 women without the disease (2002) (781)
Assessing ecosystem health. (1998) (752)
The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection (2009) (690)
Cellular immune responses to HIV (2001) (683)
Rapid Effector Function in CD8+ Memory T Cells (1997) (682)
Standardized mortality ratios and the "healthy worker effect": Scratching beneath the surface. (1976) (674)
Molecular analysis of the association of HLA-B53 and resistance to severe malaria (1992) (665)
Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. (2000) (651)
Acute HIV-1 Infection. (2011) (615)
A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. (1999) (571)
The urban environment and health in a world of increasing globalization: issues for developing countries. (2000) (531)
Characterization of CD4+ CTLs Ex Vivo1 (2002) (517)
Large clonal expansions of CD8+ T cells in acute infectious mononucleosis (1996) (515)
Solar Ultraviolet Radiation: Global burden of disease from solar ultraviolet radiation (2006) (504)
Clustered Mutations in HIV-1 Gag Are Consistently Required for Escape from Hla-B27–Restricted Cytotoxic T Lymphocyte Responses (2001) (504)
The human major histocompatibility complex class Ib molecule HLA‐E binds signal sequence‐derived peptides with primary anchor residues at positions 2 and 9 (1997) (494)
Climate Change and Human Health. Risks and Responses (2003) (488)
Prisoners of the proximate: loosening the constraints on epidemiology in an age of change. (1999) (481)
Ecosystems and human well-being - Synthesis: A Report of the Millennium Ecosystem Assessment (2005) (465)
Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection (2004) (463)
A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody (1979) (463)
HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides (1988) (459)
Common Genetic Variation and the Control of HIV-1 in Humans (2009) (448)
Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. (2008) (446)
Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants (1994) (443)
Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. (1998) (437)
Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2 (1987) (430)
Environmental exposure to lead and children's intelligence at the age of seven years. The Port Pirie Cohort Study. (1992) (421)
Port Pirie Cohort Study: environmental exposure to lead and children's abilities at the age of four years. (1988) (414)
HIV-1-Specific Mucosal CD8+ Lymphocyte Responses in the Cervix of HIV-1-Resistant Prostitutes in Nairobi1 (2000) (412)
Crystal structure of the complex between human CD8αα and HLA-A2 (1997) (409)
HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant (1993) (398)
HLA‐E is expressed on trophoblast and interacts with CD94 / NKG2 receptors on decidual NK cells (2000) (395)
Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule. (1990) (388)
Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy (1999) (388)
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. (1999) (361)
Ecosystems and Human Well-being: Health Synthesis (2005) (357)
Antigenic oscillations and shifting immunodominance in HIV-1 infections (1995) (357)
Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study (2014) (356)
CD56bright Human NK Cells Differentiate into CD56dim Cells: Role of Contact with Peripheral Fibroblasts (2007) (355)
Escape of human immunodeficiency virus from immune control. (1997) (352)
Escape from the Dominant HLA-B27-Restricted Cytotoxic T-Lymphocyte Response in Gag Is Associated with a Dramatic Reduction in Human Immunodeficiency Virus Type 1 Replication (2007) (347)
Effective Induction of Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes in Macaques by Using a Multiepitope Gene and DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccination Regimen (1999) (346)
TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL (1997) (341)
Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. (1999) (335)
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia (2007) (334)
A structural basis for immunodominant human T cell receptor recognition (2003) (332)
A human lymphocyte‐associated antigen involved in cell‐mediated lympholysis (1983) (315)
A New Look at T Cells (1998) (314)
Planetary Overload. Global Environmental Change and the Health of the Human Species (1995) (311)
T Cell Responses to Whole SARS Coronavirus in Humans1 (2008) (310)
Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. (1991) (310)
Excess mortality in England and Wales, and in Greater London, during the 1995 heatwave. (1998) (308)
Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells (1984) (303)
Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis (2005) (301)
Occupational stress and health among factory workers. (1979) (299)
Transmission of Single HIV-1 Genomes and Dynamics of Early Immune Escape Revealed by Ultra-Deep Sequencing (2010) (297)
Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line. (1986) (286)
TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide (1998) (285)
Th17 Cells Expressing KIR3DL2+ and Responsive to HLA-B27 Homodimers Are Increased in Ankylosing Spondylitis (2011) (284)
Induction of AIDS Virus-Specific CTL Activity in Fresh, Unstimulated Peripheral Blood Lymphocytes from Rhesus Macaques Vaccinated with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen1 (2000) (276)
Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes (1987) (272)
Tetrameric Complexes of Human Histocompatibility Leukocyte Antigen (HLA)-G Bind to Peripheral Blood Myelomonocytic Cells (1999) (269)
Induction of Fas Ligand Expression by HIV Involves the Interaction of Nef with the T Cell Receptor ζ Chain (1999) (268)
Cell-surface expression and immune receptor recognition of HLA-B27 homodimers. (2002) (265)
Mature CD8(+) T lymphocyte response to viral infection during fetal life. (2003) (264)
Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection. (1996) (264)
CD56bright NK Cells Are Enriched at Inflammatory Sites and Can Engage with Monocytes in a Reciprocal Program of Activation1 (2004) (264)
Longitudinal COVID-19 profiling associates IL-1Ra and IL-10 with disease severity and RANTES with mild disease. (2020) (263)
Characterization of the CD4+ T Cell Response to Epstein-Barr Virus during Primary and Persistent Infection (2003) (262)
Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine (2007) (261)
HIV vaccines 1983–2003 (2003) (258)
Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA- and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV-1 Gag Coupled to CD8+ T-Cell Epitopes (2006) (251)
Polyfunctional T cell responses are a hallmark of HIV‐2 infection (2008) (247)
Molecular Signatures Distinguish Human Central Memory from Effector Memory CD8 T Cell Subsets1 (2005) (247)
Broadly targeted CD8+ T cell responses restricted by major histocompatibility complex E (2016) (247)
Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease. (1976) (246)
A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17. (1980) (244)
Recognition of HLA-B27 and related antigen by a monoclonal antibody. (1982) (240)
Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses. (2001) (239)
The Port Pirie cohort study: maternal blood lead and pregnancy outcome. (1986) (239)
CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects. (2001) (239)
Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals (2013) (238)
Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime. (1998) (237)
A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans. (2004) (236)
A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals. (1999) (236)
LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. (1997) (233)
Terminal transferase-positive human bone marrow cells exhibit the antigenic phenotype of common acute lymphoblastic leukemia. (1979) (231)
Cancer in migrants to Australia: extending the descriptive epidemiological data. (1988) (227)
Functions of nonclassical MHC and non-MHC-encoded class I molecules. (1999) (225)
Patterns of gastro‐intestinal cancer in european migrants to Australia: The role of dietary change (1980) (224)
Class 1 major histocompatibility complex antigens on human extra-villous trophoblast. (1984) (224)
Two monoclonal antiplatelet antibodies as markers of human megakaryocyte maturation: immunofluorescent staining and platelet peroxidase detection in megakaryocyte colonies and in in vivo cells from normal and leukemic patients. (1982) (220)
Patterns of Immunodominance in HIV-1–specific Cytotoxic T Lymphocyte Responses in Two Human Histocompatibility Leukocyte Antigens (HLA)-identical Siblings with HLA-A*0201 Are Influenced by Epitope Mutation (1997) (217)
Functional characterization of HLA‐F and binding of HLA‐F tetramers to ILT2 and ILT4 receptors (2000) (217)
Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort Study. (2015) (215)
Millennium Ecosystem Assessment Synthesis Report (2005) (212)
Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E. (1998) (211)
Evasion of Cytotoxic T Lymphocyte (CTL) Responses by Nef-dependent Induction of Fas Ligand (CD95L) Expression on Simian Immunodeficiency Virus–infected Cells (1997) (207)
Immune responses in HIV-exposed seronegatives: have they repelled the virus? (1995) (205)
Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques (1995) (205)
Circulating and Tissue-Resident CD4+ T Cells With Reactivity to Intestinal Microbiota Are Abundant in Healthy Individuals and Function Is Altered During Inflammation (2017) (201)
Climate change and human health. An assessment by a Task Group on behalf of the World Health Organization the World Meteorological Organization and the United Nations Environment Programme. (1996) (200)
Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya. (2000) (197)
Lymphoblastoid cells express HLA‐B27 homodimers both intracellularly and at the cell surface following endosomal recycling (2003) (196)
Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance. (2009) (194)
Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1. (2014) (193)
Vertical T cell immunodominance and epitope entropy determine HIV-1 escape. (2012) (192)
HIV Evolution in Early Infection: Selection Pressures, Patterns of Insertion and Deletion, and the Impact of APOBEC (2009) (192)
The human thymic microenvironment: an immunohistologic study. (1980) (192)
T Cell Responses in Dengue Hemorrhagic Fever: Are Cross-Reactive T Cells Suboptimal?1 (2006) (189)
Oligoclonal Expansions of CD8+ T Cells in Chronic HIV Infection Are Antigen Specific (1998) (186)
HIV-1 Evolution and Disease Progression (1996) (185)
Recognition of carbohydrate by major histocompatibility complex class I- restricted, glycopeptide-specific cytotoxic T lymphocytes (1994) (185)
CD8(+) T-cell selection, function, and death in the primary immune response in vivo. (2000) (183)
An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. (1996) (182)
Diet, acetylator phenotype, and risk of colorectal neoplasia (1996) (181)
Longitudinal Phenotypic Analysis of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes: Correlation with Disease Progression (1999) (179)
Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma. (2001) (178)
Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. (1996) (175)
An epidemiologic study of mortality within a cohort of rubber workers, 1964-72. (1974) (174)
Leucocyte typing III : white cell differentiation antigens (1987) (172)
T Cell Cross-Reactivity and Conformational Changes during TCR Engagement (2004) (171)
Revealing the role of CD4+ T cells in viral immunity (2012) (170)
Enhanced: The Need for a Global HIV Vaccine Enterprise (2003) (168)
Monoclonal Antibody to Human Platelet Glycoprotein I I. IMMUNOLOGICAL STUDIES (1981) (167)
Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. (1995) (166)
Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection (2000) (165)
The T-cell response to HIV. (2012) (165)
Human Naive CD8 T Cells Down-Regulate Expression of the WNT Pathway Transcription Factors Lymphoid Enhancer Binding Factor 1 and Transcription Factor 7 (T Cell Factor-1) following Antigen Encounter In Vitro and In Vivo1 (2006) (162)
Declining blood lead levels and changes in cognitive function during childhood: the Port Pirie Cohort Study. (1998) (161)
Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): a new receptor protecting lymphocytes from the death ligand TRAIL. (1998) (160)
Copy Number Variation of KIR Genes Influences HIV-1 Control (2011) (158)
Fitness Costs and Diversity of the Cytotoxic T Lymphocyte (CTL) Response Determine the Rate of CTL Escape during Acute and Chronic Phases of HIV Infection (2011) (156)
Lifetime low-level exposure to environmental lead and children's emotional and behavioral development at ages 11-13 years. The Port Pirie Cohort Study. (1999) (156)
DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice. (1998) (152)
Role of cellular immunity in protection against HIV infection. (1997) (151)
Antagonist HIV-1 Gag Peptides Induce Structural Changes in HLA B8 (1996) (151)
HLA-B27 Heavy Chain Homodimers Are Expressed in HLA-B27 Transgenic Rodent Models of Spondyloarthritis and Are Ligands for Paired Ig-Like Receptors1 (2004) (149)
Increased frequency of HLA-Cw3 and HLA-Dw4 in rheumatoid arthritis. (1977) (148)
Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. (1986) (147)
Distribution of HLA class 1 antigens in normal human tissue and in mammary cancer. (1981) (145)
HLA class I typing by PCR: HLA-B27 and an African B27 subtype (1991) (143)
HIV‐1 down‐regulates the expression of CD1d via Nef (2006) (143)
T Cell Responses and Viral Escape (1998) (143)
Mortality among rubber workers: Relationship to specific jobs. (1976) (141)
Inappropriate use of daily mortality analyses to estimate longer-term mortality effects of air pollution. (1998) (140)
Monoclonal Antibody to Human Platelet Glycoprotein I II. EFFECTS ON HUMAN PLATELET FUNCTION (1981) (140)
CELL-MEDIATED CYTOTOXIC RESPONSE TO RESPIRATORY SYNCYTIAL VIRUS IN INFANTS WITH BRONCHIOLITIS (1987) (139)
HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2. (1994) (138)
Methods of assessing human health vulnerability and public health adaptation to climate change (2003) (137)
Increased frequencies of CD4+CD25high regulatory T cells in acute dengue infection (2007) (135)
Short-term associations between outdoor air pollution and mortality in London 1992-4. (1999) (134)
Opinion — vaccines: The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible? (2002) (134)
Rapid death of adoptively transferred T cells in acquired immunodeficiency syndrome. (1999) (134)
Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers. (2006) (133)
Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57 (2002) (133)
A novel method for autophagy detection in primary cells (2012) (133)
HIV-Host Interactions: Implications for Vaccine Design. (2016) (129)
HIV-specific Cytotoxic T Cells from Long-Term Survivors Select a Unique T Cell Receptor (2004) (129)
How HIV defeats the immune system. (1995) (129)
The hyaluronidase activities of some Southeast Asian snake venoms. (1988) (127)
Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes. Use of analogues to orientate the matrix peptide in the HLA-A2 binding site (1988) (126)
Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction. (2007) (125)
Aromatic residues at the edge of the antibody combining site facilitate viral glycoprotein recognition through membrane interactions (2010) (125)
Observations on the Evaluation of Occupational Mortality Data (1975) (123)
BirA enzyme: production and application in the study of membrane receptor-ligand interactions by site-specific biotinylation. (1999) (122)
Interaction of HLA‐B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA‐B27 heterotrimers, is independent of the sequence of bound peptide (2007) (122)
Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. (1996) (122)
Conservation of T cell receptor usage by HLA B27‐restricted influenza‐specific cytotoxic T lymphocytes suggests a general pattern for antigen‐specific major histocompatibility complex class I‐restricted responses (1993) (121)
HLA-A2 subtypes are functionally distinct in peptide binding and presentation (1995) (120)
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients (2020) (120)
DECLINING T-CELL IMMUNITY TO INFLUENZA, 1977-82 (1983) (120)
HLA-peptide tetrameric complexes. (1998) (120)
Cytotoxic T-cell recognition of HIV proteins and peptides. (1991) (120)
Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicity. (2007) (118)
A Hybrid Epidemiologic Study Design Useful in Estimating Relative Risk (1975) (117)
Structural and functional properties of the human notch-1 ligand binding region. (2004) (116)
The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vbeta domain. (2008) (115)
Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors. (1999) (115)
Have increases in solar ultraviolet exposure contributed to the rise in incidence of non-Hodgkin's lymphoma? (1996) (115)
Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime. (1999) (114)
Influenza virus‐specific cytotoxic T cells in man; induction and properties of the cytotoxic cell (1978) (114)
Carbon dioxide emissions (1996) (114)
Strong Human Immunodeficiency Virus (HIV)-Specific Cytotoxic T-Lymphocyte Activity in Sydney Blood Bank Cohort Patients Infected with nef-Defective HIV Type 1 (1999) (113)
Relationship between Functional Profile of HIV-1 Specific CD8 T Cells and Epitope Variability with the Selection of Escape Mutants in Acute HIV-1 Infection (2011) (113)
A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides (1993) (111)
Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope (2006) (110)
Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA‐B*2705 (2005) (110)
The human cytotoxic T cell response to influenza A vaccination. (1981) (110)
Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2. (1997) (110)
High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. (1990) (109)
HLA and MHC: Genes, Molecules And Function (1997) (108)
Maintenance of HIV-Specific CD4+ T Cell Help Distinguishes HIV-2 from HIV-1 Infection1 (2006) (107)
Effect of mutations and variations of HLA-A2 on recognition of a virus peptide epitope by cytotoxic T lymphocytes. (1988) (106)
Subpopulations of normal and leukemic human thymocytes: an analysis with the use of monoclonal antibodies. (1980) (105)
Monoclonal antibodies in clinical medicine (1982) (105)
Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27. (1990) (104)
Environment and health: 2. Global climate change and health. (2000) (104)
Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS. (1999) (103)
Clonal Selection, Clonal Senescence, and Clonal Succession: The Evolution of the T Cell Response to Infection with a Persistent Virus1 (2002) (102)
High Pro-Inflammatory Cytokine Secretion and Loss of High Avidity Cross-Reactive Cytotoxic T-Cells during the Course of Secondary Dengue Virus Infection (2007) (101)
Activation of invariant NKT cells enhances the innate immune response and improves the disease course in influenza A virus infection (2008) (101)
Relative rate and location of intra-host HIV evolution to evade cellular immunity are predictable (2016) (100)
Cross‐clade recognition of p55 by cytotoxic T lymphocytes in HIV‐1 infection (1998) (99)
A human X-linked antigen defined by a monoclonal antibody (1980) (99)
On the utility of proportional mortality analysis. (1978) (99)
Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised (1995) (97)
Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa. (2008) (96)
Determinants of blood lead concentrations to age 5 years in a birth cohort study of children living in the lead smelting city of Port Pirie and surrounding areas. (1992) (96)
Lead Exposure and Child Development: An International Assessment (1989) (95)
Solvent exposure and leukemia among rubber workers: an epidemiologic study. (1975) (95)
Global environmental change and human population health: a conceptual and scientific challenge for epidemiology. (1993) (95)
Expansion and Diversification of Virus-Specific T Cells following Immunization of Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Individuals with a Recombinant Modified Vaccinia Virus Ankara/HIV-1 Gag Vaccine (2006) (94)
Collapse. How Societies Choose to Fail or Succeed. Jared Diamond. New York: Viking, 2004. (2006) (94)
Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors. (1997) (94)
Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection. (2016) (94)
HLA B37 determines an influenza A virus nucleoprotein epitope recognized by cytotoxic T lymphocytes (1986) (93)
Immune perturbations in HIV-1–infected individuals who make broadly neutralizing antibodies (2016) (93)
T cell selection during the evolution of CD8+ T cell memory in vivo (1998) (93)
Maintenance of MHC polymorphism (1992) (93)
Human Immunodeficiency Virus Type 1- and Cytomegalovirus-Specific Cytotoxic T Lymphocytes Can Persist at High Frequency for Prolonged Periods in the Absence of Circulating Peripheral CD4+ T Cells (2000) (92)
Deficiency of a subset of T-cells with immunoregulatory properties in sarcoidosis (2005) (92)
Different MHC class I alleles compete for presentation of overlapping viral epitopes. (1995) (92)
Reduced allorecognition of adenovirus-2 infected cells. (1987) (91)
Lessons learned from HIV-1 vaccine trials: new priorities and directions (2012) (90)
Interethnic genetic differentiation in Africa: HLA class I antigens in The Gambia. (1992) (90)
The T cell repertoire in infection and vaccination: implications for control of persistent viruses. (2007) (89)
A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complex. (2001) (89)
Pivotal Advance: Invariant NKT cells reduce accumulation of inflammatory monocytes in the lungs and decrease immune‐pathology during severe influenza A virus infection (2012) (89)
Elevation of Intact and Proteolytic Fragments of Acute Phase Proteins Constitutes the Earliest Systemic Antiviral Response in HIV-1 Infection (2010) (89)
Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice. (1998) (89)
Virus infections: escape, resistance, and counterattack. (2001) (89)
Dynamics of T Cell Responses in HIV Infection1 (2002) (89)
Human CD4+ T Cells Are Predominantly Distributed among Six Phenotypically and Functionally Distinct Subsets1 (2005) (88)
Port Pirie Cohort study: childhood blood lead and neuropsychological development at age two years. (1988) (88)
Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection. (2007) (87)
HLA restriction of human cytotoxic T lymphocytes specific for influenza virus. Poor recognition of virus associated with HLA A2 (1978) (87)
Time trends in colo-rectal cancer mortality in relation to food and alcohol consumption: United States, United Kingdom, Australia and New Zealand. (1979) (86)
Conserved Footprints of APOBEC3G on Hypermutated Human Immunodeficiency Virus Type 1 and Human Endogenous Retrovirus HERV-K(HML2) Sequences (2008) (86)
Sequential Broadening of CTL Responses in Early HIV-1 Infection Is Associated with Viral Escape (2007) (86)
Immunohistochemical analysis of HLA (A, B, C) antigens in liver disease using a monoclonal antibody. (1981) (85)
Development of a DNA-MVA/HIVA vaccine for Kenya. (2002) (85)
Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population (2011) (84)
A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques. (2002) (83)
Distinct Recognition of Non-Clade B Human Immunodeficiency Virus Type 1 Epitopes by Cytotoxic T Lymphocytes Generated from Donors Infected in Africa (1999) (83)
Deletion of the CD4 silencer element supports a stochastic mechanism of thymocyte lineage commitment (2001) (82)
Proteome-wide analysis of HIV-specific naive and memory CD4+ T cells in unexposed blood donors (2014) (82)
Peptide selection by class I molecules of the major histocompatibility complex (1993) (82)
Long peptides induce polyfunctional T cells against conserved regions of HIV‐1 with superior breadth to single‐gene vaccines in macaques (2010) (82)
The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus (1995) (82)
Allergen-specific CD8(+) T cells and atopic disease. (2002) (81)
Antiviral inhibitory capacity of CD8+ T cells predicts the rate of CD4+ T-cell decline in HIV-1 infection. (2012) (81)
Anti-HIV cellular immunity: recent advances towards vaccine design. (1999) (81)
Specificity of T cells in synovial fluid: high frequencies of CD8+ T cells that are specific for certain viral epitopes (2000) (81)
How important is the 'quality' of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection? (2001) (81)
RANTES activates antigen-specific cytotoxic T lymphocytes in a mitogen-like manner through cell surface aggregation. (2000) (80)
Lack of Epstein-Barr virus- and HIV-specific CD27− CD8+ T cells is associated with progression to viral disease in HIV-infection (2002) (80)
The impacts of climate change on three health outcomes: Temperature-related mortality and hospitalisations, salmonellosis and other bacterial gastroenteritis, and population at risk from dengue (2008) (80)
Structures of Three HIV-1 HLA-B*5703-Peptide Complexes and Identification of Related HLAs Potentially Associated with Long-Term Nonprogression12 (2005) (80)
Design and validation of an enzyme-linked immunospot assay for use in clinical trials of candidate HIV vaccines. (2002) (79)
The health of persons, populations, and planets: epidemiology comes full circle. (1995) (79)
Rapid Effector Function in CD 8 1 Memory T Cells (1997) (78)
Ex Vivo Phenotype and Frequency of Influenza Virus-Specific CD4 Memory T Cells (2004) (78)
Activation of Invariant NKT Cells in Early Phase of Experimental Autoimmune Encephalomyelitis Results in Differentiation of Ly6Chi Inflammatory Monocyte to M2 Macrophages and Improved Outcome (2012) (77)
Long-term mortality profile of heavily-exposed lead smelter workers. (1982) (77)
A suppressor T cell in the human mixed lymphocyte reaction (1977) (77)
Peptide anchor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognition (1995) (76)
Quantitating T Cell Cross-Reactivity for Unrelated Peptide Antigens1 (2009) (76)
Prospects for an AIDS vaccine. (2003) (75)
Complex mixtures and cancer risk. (1990) (75)
Vaccines that stimulate T cell immunity to HIV-1: the next step (2014) (75)
Cytotoxic T lymphocytes specific for influenza virus. (1994) (74)
Protective Efficacy of Serially Up-Ranked Subdominant CD8+ T Cell Epitopes against Virus Challenges (2011) (74)
Use of B cell-bound HLA-A2 class I monomers to generate high-avidity, allo-restricted CTLs against the leukemia-associated protein Wilms tumor antigen. (2004) (74)
Climate Change and the Health of Nations: Famines, Fevers, and the Fate of Populations (2017) (73)
High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A*0201-positive subjects during multiple viral coinfections. (2000) (73)
Tooth lead levels and IQ in school-age children: the Port Pirie Cohort Study. (1994) (73)
Comparing Pooled Peptides with Intact Protein for Accessing Cross-presentation Pathways for Protective CD8+ and CD4+ T Cells* (2009) (73)
Dynamics of T Cell Responses in HIV Infection (2002) (72)
Environmental Exposure to Lead and Childrenʼs Intelligence at the Age of Seven Years: The Port Pirie Cohort Study (1993) (71)
A critical role for conserved residues in the cleft of HLA-A2 in presentation of a nonapeptide to T cells. (1992) (71)
Gene set analysis of lung samples provides insight into pathogenesis of progressive, fibrotic pulmonary sarcoidosis. (2010) (71)
Global Climate change and health: an old story writ large (2003) (71)
Cytotoxic T cells in HIV2 seropositive Gambians. Identification of a virus-specific MHC-restricted peptide epitope. (1993) (70)
The Port Pirie Cohort Study: lead effects on pregnancy outcome and early childhood development. (1987) (70)
Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection (2018) (70)
Impact of climatic and other environmental changes on food production and population health in the coming decades (2001) (69)
Invited commentary--"molecular epidemiology": new pathway or new travelling companion? (1994) (69)
Climate variability and Ross River virus transmission (2002) (68)
High levels of virus-specific CD4+ T cells predict severe pandemic influenza A virus infection. (2012) (68)
Complete nucleotide sequence of a unique HLA class I C locus product expressed on the human choriocarcinoma cell line BeWo. (1989) (67)
The sustainability transition: a new challenge. (2000) (67)
Characterization of blast cells in chronic granulocytic leukaemia in transformation, acute myelofibrosis and undifferentiated leukaemia II. STUDIES WITH MONOCLONAL ANTIBODIES AND TERMINAL TRANSFERASE (1985) (67)
Differences in peptide presentation between B27 subtypes: the importance of the P1 side chain in maintaining high affinity peptide binding to B*2703. (1994) (66)
TLR2 engagement on memory CD8+ T cells improves their cytokine‐mediated proliferation and IFN‐γ secretion in the absence of Ag (2009) (66)
Reduction of Natural Killer but Not Effector CD8 T Lymphoyctes in Three Consecutive Cases of Severe/Lethal H1N1/09 Influenza A Virus Infection (2010) (66)
Initial HIV-1 Antigen-Specific CD8+ T Cells in Acute HIV-1 Infection Inhibit Transmitted/Founder Virus Replication (2012) (66)
Bystander T cell activation--implications for HIV infection and other diseases. (2006) (65)
The immunology of influenza. (1985) (65)
HLA-DR2 subtypes form an additional supertypic family of DR beta alleles. (1987) (65)
APOBEC3G-Induced Hypermutation of Human Immunodeficiency Virus Type-1 Is Typically a Discrete “All or Nothing” Phenomenon (2012) (65)
Lead in the placenta, membranes, and umbilical cord in relation to pregnancy outcome in a lead-smelter community. (1991) (63)
Strong TCR Conservation and Altered T Cell Cross-Reactivity Characterize a B*57-Restricted Immune Response in HIV-1 Infection12 (2006) (63)
A suppressor T cell of the mixed lymphocyte reaction in man specific for the stimulating alloantigen. Evidence that identity at HLA-D between suppressor and responder is required for suppression (1978) (63)
Immunization of human HIV‐seronegative volunteers with recombinant p17/p24: Ty virus‐like particles elicits HIV‐1 p24‐specific cellular and humoral immune responses (1993) (62)
Requirement of the Proteasome for the Trimming of Signal Peptide-derived Epitopes Presented by the Nonclassical Major Histocompatibility Complex Class I Molecule HLA-E* (2003) (62)
Sociodemographic factors modifying the effect of environmental lead on neuropsychological development in early childhood. (1992) (62)
Lessons from IAVI-006, a phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers. (2008) (61)
Genetic modulation of antigen presentation by HLA-B27 molecules (1992) (61)
Effects of Cytotoxic T Lymphocytes (CTL) Directed against a Single Simian Immunodeficiency Virus (SIV) Gag CTL Epitope on the Course of SIVmac239 Infection (2002) (61)
Environmental change, climate and health : issues and research methods (2002) (60)
Lack of toxicity and persistence in the mouse associated with administration of candidate DNA- and modified vaccinia virus Ankara (MVA)-based HIV vaccines for Kenya. (2002) (60)
Examination of Influenza Specific T Cell Responses after Influenza Virus Challenge in Individuals Vaccinated with MVA-NP+M1 Vaccine (2013) (60)
Cytotoxic T cell recognition of Epstein‐Barr virus‐infected B cells. II. Blocking studies with monoclonal antibodies to HLA determinants (1981) (60)
Direct relationship between virus load and systemic immune activation in HIV-2 infection. (2010) (59)
HLA-B may be more protective against HIV-1 than HLA-A because it resists negative regulatory factor (Nef) mediated down-regulation (2012) (59)
Cytotoxic T–cell abundance and virus load in human immunodeficiency virus type 1 and human T–cell leukaemia virus type 1 (2001) (59)
Changes in frequency of HIV-1-specific cytotoxic T cell precursors and circulating effectors after combination antiretroviral therapy in children. (1999) (59)
The role of HLA-B27 in spondyloarthritis (1999) (59)
Linking Ecosystem Services and Human Well-being (2005) (58)
Safety and tolerability of recombinant modified vaccinia virus Ankara expressing an HIV-1 gag/multiepitope immunogen (MVA.HIVA) in HIV-1-infected persons receiving combination antiretroviral therapy. (2007) (58)
Impacts of global environmental change on future health and health care in tropical countries. (1998) (58)
Air and Water Pollution: Burden and Strategies for Control (2006) (58)
Megakaryocyte cultures in the chronic phase and in the blast crisis of chronic myeloid leukaemia: studies on the differentiation of the megakaryocyte progenitors and on the maturation of megakaryocytes in vitro (1982) (57)
An Early HIV Mutation within an HLA-B*57-Restricted T Cell Epitope Abrogates Binding to the Killer Inhibitory Receptor 3DL1 (2011) (57)
CCL3L1 and HIV/AIDS susceptibility (2009) (57)
Antigen-Specific Expansion of Cytotoxic T Lymphocytes in Acute Measles Virus Infection (1999) (57)
CD4+ T Follicular Helper Cells in Human Tonsils and Blood Are Clonally Convergent but Divergent from Non-Tfh CD4+ Cells (2020) (57)
CD4−CD8αα Subset of CD1d-Restricted NKT Cells Controls T Cell Expansion1 (2004) (56)
Vaccine route, dose and type of delivery vector determine patterns of primary CD8+ T cell responses (2005) (56)
Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome (2012) (56)
Efficient priming of antigen-specific cytotoxic T lymphocytes by human cord blood dendritic cells. (2003) (55)
Extensive genetic diversity in the HLA class II region of Africans, with a focally predominant allele, DRB1*1304. (1992) (55)
A prospective study of serial maternal serum zinc levels and pregnancy outcome. (1982) (55)
Multilayered Defense in HLA-B51–Associated HIV Viral Control (2011) (54)
Specificity of cytotoxic T lymphocytes stimulated with influenza virus. Studies in mice and humans. (1985) (52)
Engineering RENTA, a DNA prime-MVA boost HIV vaccine tailored for Eastern and Central Africa (2004) (52)
Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide. (1993) (52)
T cell re-targeting to EBV antigens following TCR gene transfer: CD28-containing receptors mediate enhanced antigen-specific IFNgamma production. (2006) (52)
Mutation of the alpha 2 domain disulfide bridge of the class I molecule HLA-A*0201. Effect on maturation and peptide presentation. (1994) (52)
Human CD4+ Memory T Cells Are Preferential Targets for Bystander Activation and Apoptosis1 (2009) (52)
HIV/AIDS. HLA leaves its footprints on HIV. (2002) (52)
Epitope specificity of clonally expanded populations of CD8+ T cells found within the joints of patients with inflammatory arthritis. (2001) (51)
The ILT family of leukocyte receptors. (2000) (51)
Respiratory function and symptoms: an environmental-epidemiological study of rubber workers exposed to a phenolformaldehyde type resin. (1976) (51)
HLA-B27: natural function and pathogenic role in spondyloarthritis (2002) (50)
Dendritic Cells Are Less Susceptible to Human Immunodeficiency Virus Type 2 (HIV-2) Infection than to HIV-1 Infection (2007) (50)
Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassical class I molecule HLA-E. (1999) (49)
Clostridium perfringens enterotoxin is a superantigen reactive with human T cell receptors V beta 6.9 and V beta 22 (1992) (49)
DNA vaccines against human immunodeficiency virus type 1 (2004) (48)
Analysis of mutant HLA-A2 molecules. Differential effects on peptide binding and CTL recognition. (1994) (48)
Identification of T cell receptor recognition residues for a viral peptide presented by HLA B27 (1994) (48)
Reappraisal of the Relationship between the HIV-1-Protective Single-Nucleotide Polymorphism 35 Kilobases Upstream of the HLA-C Gene and Surface HLA-C Expression (2011) (48)
Loss of DNAM‐1 contributes to CD8+ T‐cell exhaustion in chronic HIV‐1 infection (2010) (48)
Memory CD8+ T cells in HIV infection. (2000) (47)
Multiple T cell expansions are found in the blood and synovial fluid of patients with reactive arthritis. (1997) (47)
Identification of Effective Subdominant Anti-HIV-1 CD8+ T Cells Within Entire Post-infection and Post-vaccination Immune Responses (2015) (47)
Virus-specific antibody secreting cell, memory B-cell, and sero-antibody responses in the human influenza challenge model. (2014) (47)
Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes (1989) (47)
Influenza virus-specific cytotoxic T lymphocytes recognize HLA-molecules. Blocking by monoclonal anti-HLA antibodies. (1980) (47)
Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2. (1989) (47)
Bias and confounding in molecular epidemiological studies: special considerations. (1998) (47)
Evidence of widespread binding of HLA class I molecules to peptides (1990) (47)
Seeking a global perspective on air pollution and health. (1999) (46)
Interferon-induced transmembrane protein-3 rs12252-C is associated with rapid progression of acute HIV-1 infection in Chinese MSM cohort (2015) (46)
HIV vaccines (2006) (46)
Tetrameric complexes of HLA-E, HLA-F, and HLA-G. (2002) (46)
Effects of monoclonal antibodies to the a and β chains of the human lymphocyte function‐associated (H‐LFA‐1) antigen on T lymphocyte functions (1985) (46)
Biodistribution and persistence of an MVA-vectored candidate HIV vaccine in SIV-infected rhesus macaques and SCID mice. (2005) (46)
Screening for HIV-specific T-cell responses using overlapping 15-mer peptide pools or optimized epitopes (2004) (45)
Therapeutic immunization of highly active antiretroviral therapy-treated HIV-1-infected patients: safety and immunogenicity of an HIV-1 gag/poly-epitope DNA vaccine (2005) (45)
Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding (2018) (45)
Progress in understanding HLA and disease associations. (1987) (44)
CARD 15 gene mutations in sarcoidosis (2005) (44)
An Antigenic Threshold for Maintaining Human Immunodeficiency Virus Type 1-specific Cytotoxic T Lymphocytes (2000) (44)
Homocysteine modification of HLA antigens and its immunological consequences (1996) (44)
Avian influenza A(H5N1) viruses can directly infect and replicate in human gut tissues. (2010) (43)
HIV-1 Env-specific cytotoxic T-lymphocyte responses in exposed, uninfected Kenyan sex workers: a prospective analysis (2004) (43)
Class I cross-restricted T cells reveal low responder allele due to processing of viral antigen (1989) (43)
The Duffy antigen receptor for chemokines null promoter variant does not influence HIV-1 acquisition or disease progression. (2009) (43)
Extensive HLA-driven viral diversity following a narrow-source HIV-1 outbreak in rural China. (2011) (43)
Combined single‐clade candidate HIV‐1 vaccines induce T cell responses limited by multiple forms of in vivo immune interference (2007) (42)
Clinical applications of monoclonal antibodies. (1980) (42)
A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A. (2013) (42)
Climate change health impacts in Australia : effects of dramatic CO2 emission reductions (2005) (42)
Heterogeneity of breast cancer risk within the South Asian female population in England: a population-based case–control study of first-generation migrants (2004) (40)
Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara. (2003) (40)
HIV T cell vaccines, the importance of clades. (2002) (40)
An HIV-1 and HIV-2 cross-reactive cytotoxic T-cell epitope. (1990) (40)
The AIDS incubation period in the UK estimated from a national register of HIV seroconverters (1998) (40)
HLA Leaves Its Footprints on HIV (2002) (39)
Health and Climate Change 4 Public health benefi ts of strategies to reduce greenhouse-gas emissions: food and agriculture (2009) (39)
The role of cytotoxic T-cells in HIV infection. (1998) (39)
The Role of MHC-E in T Cell Immunity Is Conserved among Humans, Rhesus Macaques, and Cynomolgus Macaques (2018) (39)
Identification of H5N1-specific T-cell responses in a high-risk cohort in vietnam indicates the existence of potential asymptomatic infections. (2012) (39)
Prime-boost regimens with adjuvanted synthetic long peptides elicit T cells and antibodies to conserved regions of HIV-1 in macaques (2012) (39)
A Comprehensive Analysis of Key Immune Checkpoint Receptors on Tumor-Infiltrating T Cells From Multiple Types of Cancer (2019) (38)
Production and crystallization of MHC class I B allele single peptide complexes (1996) (38)
Differences in HIV-Specific T Cell Responses between HIV-Exposed and -Unexposed HIV-Seronegative Individuals (2011) (38)
Combined structural and immunological refinement of HIV‐1 HLA‐B8‐restricted cytotoxic T lymphocyte epitopes (1997) (38)
An antigen processing polymorphism revealed by HLA‐B8‐restricted cytotoxic T lymphocytes which does not correlate with TAP gene polymorphism (1993) (38)
Expression of a single-chain HLA class I molecule in a human cell line: presentation of exogenous peptide and processed antigen to cytotoxic T lymphocytes. (1996) (38)
Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection (2018) (38)
M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenza (2017) (38)
Identification of Self-lipids Presented by CD1c and CD1d Proteins* (2011) (37)
Climatic, high tide and vector variables and the transmission of Ross River virus (2005) (37)
Production, crystallization, and preliminary X‐ray analysis of the human MHC class Ib molecule HLA‐E (1998) (37)
Suppression of the mixed lymphocyte reaction in man by a soluble T-cell factor. Specificity of the factor for both responder and stimulator (1978) (37)
Mallory bodies in alcoholic liver disease: identification of cytoplasmic filament/cell membrane and unique antigenic determinants by monoclonal antibodies. (1981) (36)
Sequence analysis of HLA-Bw53, a common West African allele, suggests an origin by gene conversion of HLA-B35. (1991) (36)
Casting a wider net: Immunosurveillance by nonclassical MHC molecules (2019) (36)
Contribution of proteasome-catalyzed peptide cis-splicing to viral targeting by CD8+ T cells in HIV-1 infection (2019) (36)
Highly avid, oligoclonal, early‐differentiated antigen‐specific CD8+ T cells in chronic HIV‐2 infection (2010) (35)
Immune recognition of HLA molecules downmodulates CD8 expression on cytotoxic T lymphocytes (1991) (35)
Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8+ Tumor-Infiltrating T Lymphocyte Responses (2019) (35)
The arrival of HLA class II tetramers. (1999) (35)
Immunisation with recombinant modified vaccinia virus Ankara expressing HIV‐1 gag in HIV‐1‐infected subjects stimulates broad functional CD4+ T cell responses (2006) (34)
Quantitation of antigen-specific CD8+ T-cell responses. (1999) (34)
Positioning of a peptide in the cleft of HLA-A2 by complementing amino acid changes. (1991) (34)
Differential processing of influenza nucleoprotein in human and mouse cells (1998) (33)
Human numbers, environment, sustainability, and health (1999) (33)
Persistent HIV-1-specific cellular responses despite prolonged therapeutic viral suppression (2002) (33)
Distinct Kinetics of Gag-Specific CD4+ and CD8+ T Cell Responses during Acute HIV-1 Infection (2012) (33)
Expression of leukocyte immunoglobulin-like receptors and natural killer receptors on virus-specific CD8+ T cells during the evolution of Epstein-Barr virus-specific immune responses in vivo. (2005) (33)
Collagen‐specific cytotoxic T lymphocyte responses in patients with ankylosing spondylitis and reactive arthritis (1994) (33)
Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes (2000) (32)
Blocking Development of a CD8+ T Cell Response by Targeting Lymphatic Recruitment of APC1 (2009) (32)
Pulmonary toxicity and acute respiratory failure associated with fludarabine monophosphate. (1992) (32)
The association between the HLA system and disease. (1977) (32)
Lymphocytes : a practical approach (2000) (32)
The T cell surface--how well do we know it? (2003) (32)
Gonococcal cervicitis is associated with reduced systemic CD8+ T cell responses in human immunodeficiency virus type 1-infected and exposed, uninfected sex workers. (2002) (32)
Recombinant Salmonella typhimurium strains that invade nonphagocytic cells are resistant to recognition by antigen-specific cytotoxic T lymphocytes (1992) (31)
Research priorities for the environment, agriculture and infectious diseases of poverty. (2013) (31)
Climate change and infectious diseases (2008) (31)
Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection (2016) (31)
Identification of a novel HLA-A24-restricted cytotoxic T-lymphocyte epitope within HIV-1 Nef. (1997) (31)
The global context for public health (2003) (31)
Induction of long‐lasting multi‐specific CD8+ T cells by a four‐component DNA‐MVA/HIVA‐RENTA candidate HIV‐1 vaccine in rhesus macaques (2006) (31)
Cohort Profile: The Flu Watch Study (2016) (30)
Fully Functional HLA B27-Restricted CD4+ as well as CD8+ T Cell Responses in TCR Transgenic Mice (2004) (30)
Structural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphisms (2012) (30)
Cytotoxic T-cell response to simian immunodeficiency virus by cynomolgus macaque monkeys immunized with recombinant vaccinia virus. (1991) (30)
Reconstitution of antigen presentation in HLA class I‐negative cancer cells with peptide‐β2m fusion molecules (2001) (30)
Induction of Human Immunodeficiency Virus Type 1-Specific T Cells by a Bluetongue Virus Tubule-Vectored Vaccine Prime-Recombinant Modified Virus Ankara Boost Regimen (2005) (30)
A review of vaccines for HIV prevention (2003) (29)
Effect of occupational and nonoccupational factors on the respiratory system of vinyl chloride and other workers. (1976) (29)
Increased detection of proliferating, polyfunctional, HIV‐1‐specific T cells in DNA‐modified vaccinia virus Ankara‐vaccinated human volunteers by cultured IFN‐γ ELISPOT assay (2009) (29)
Genes of the MHC class III region and the functions of the proteins they encode (1996) (29)
Importance of a conserved TCR J α‐encoded tyrosine for T cell recognition of an HLA B27/ peptide complex (1998) (29)
First-Class Control of HIV-1 (2010) (29)
Global environmental change as "risk factor": can epidemiology cope? (2001) (29)
LACK OF EVIDENCE FOR GENE CONVERSION IN B27 NEGATIVE ANKYLOSING-SPONDYLITIS (1987) (29)
CTLs Target Th Cells That Acquire Bystander MHC Class I-Peptide Complex from APCs (2007) (28)
Man Under Stress (1975) (28)
TCRβ spectratyping in RA: evidence of clonal expansions in peripheral blood lymphocytes (1998) (28)
Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans. (2011) (28)
Broad TCR Usage in Functional HIV-1-Specific CD8+ T Cell Expansions Driven by Vaccination during Highly Active Antiretroviral Therapy1 (2007) (28)
Is an HIV vaccine possible? (1999) (28)
The dynamics of the cellular immune response to HIV infection: implications for vaccination. (2000) (28)
Functional characteristics of HIV-1 subtype C compatible with increased heterosexual transmissibility (2009) (28)
Identification of a novel HLA-B*2705-restricted cytotoxic T-lymphocyte epitope within a conserved region of HIV-1 Nef. (1997) (27)
From hazard to habitat: rethinking environment and health. (1999) (27)
Genetic evidence for difference between intracellular and extracellular peptides in influenza A matrix peptide-specific CTL recognition. (1995) (27)
Potential underestimation of HLA-C-restricted cytotoxic T-lymphocyte responses. (1997) (27)
New templates for HIV-1 antibody-based vaccine design (2010) (27)
Definition of peptide binding motifs amongst the HLA-A*30 allelic group. (2000) (27)
Global Energy Assessment (GEA): Energy and Health (2012) (27)
Recombination-mediated escape from primary CD8+ T cells in acute HIV-1 infection (2014) (26)
Conserved Footprints of APOBEC 3 G on Hypermutated Human Immunodeficiency Virus Type 1 and Human Endogenous Retrovirus HERV-K ( HML 2 ) Sequences † (2008) (26)
T-cell recognition of influenza viral antigens. (1987) (26)
Anti‐viral cytotoxic T cells inhibit the growth of cancer cells with antibody targeted hla class I/peptide complexes in scid mice (2002) (25)
HIV‐specific cytotoxic T‐cell activity in an HIV‐exposed but uninfected infants (1993) (25)
Boosted Influenza-Specific T Cell Responses after H5N1 Pandemic Live Attenuated Influenza Virus Vaccination (2015) (25)
Optimization of peptide linker length in production of MHC class II/peptide tetrameric complexes increases yield and stability, and allows identification of antigen‐specific CD4+T cells in peripheral blood mononuclear cells (2002) (25)
Different rates of HLA class I molecule assembly which are determined by amino acid sequence in the α2 domain (2004) (25)
Design and tests of an HIV vaccine. (2002) (24)
Mental health problems among university students, and their relationship to academic failure and withdrawal. (1975) (24)
Modified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants. (2005) (23)
Novel HIV‐1 clade B candidate vaccines designed for HLA‐B*5101+ patients protected mice against chimaeric ecotropic HIV‐1 challenge (2009) (23)
Inhibition of human T lymphocyte function with monoclonal antibodies. (1984) (23)
Significance of the six peptide-binding pockets of HLA-A2.1 in influenza A matrix peptide-specific cytotoxic T-lymphocyte reactivity. (1994) (23)
An HLA class I specific monoclonal antibody that fails to bind to all HLA-A antigens. (1985) (23)
HLA-D antigens in the Japanese population. (2008) (23)
Recognition of the PB1, neuraminidase, and matrix proteins of influenza virus A/NT/60/68 by cytotoxic T lymphocytes. (1989) (22)
Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjects. (2010) (22)
Those images that yet fresh images beget (1987) (22)
Global Environmental Change and Human Health: Science Plan and Implementation Strategy (2006) (22)
National Climate Change Adaptation Research Plan for human health (2009) (22)
Cytotoxic t lymphocytes in hiv infection (1993) (22)
The Antiviral Efficacy of HIV-Specific CD8+ T-Cells to a Conserved Epitope Is Heavily Dependent on the Infecting HIV-1 Isolate (2011) (22)
Evidence for the persistence of monoclonal expansions of CD8+ T cells following primary simian immunodeficiency virus infection (1998) (21)
Progression of whole-blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in severe influenza (2018) (21)
Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes (2002) (21)
Triple bypass: complicated paths to HIV escape (2007) (21)
Identification of a novel human leukocyte antigen A26-restricted epitope in a conserved region of Gag. (1996) (21)
Global changes, invasive species, and human health (2001) (21)
HLA-E–restricted, Gag-specific CD8+ T cells can suppress HIV-1 infection, offering vaccine opportunities (2021) (20)
Early acquisition of cytolytic function and transcriptional changes in a primary CD8+ T-cell response in vivo. (2007) (20)
Optimization of peptide linker length in production of MHC class II/peptide tetrameric complexes increases yield and stability, and allows identification of antigen-specific CD4+T cells in peripheral blood mononuclear cells. (2002) (20)
HLA class-I-transgenic mice as model system to study MHC-restricted antigen recognition in man. (1990) (20)
Global environmental changes (2006) (20)
The use of biological markers as predictive early-outcome measures in epidemiological research. (1997) (20)
Identification of a novel HLA-A25-restricted epitope in a conserved region of p24 gag (positions 71-80). (1996) (19)
Early‐life hygiene‐related factors affect risk of central nervous system demyelination and asthma differentially (2013) (19)
Health consequences of global climate change (2001) (19)
Setting environmental exposure standards: the role of the epidemiologist. (1989) (19)
Identification of novel HIV-1-derived HLA-E-binding peptides (2018) (19)
Purification and inactivation of the factor X activator of Russell's viper venom with monoclonal antibodies. (1983) (19)
Recognition of a human T-lymphocyte differentiation antigen by an IgM monoclonal antibody. (1981) (19)
Functional and biochemical subtypes of the haplotype HLA-DR3 in patients with celiac disease or idiopathic membranous nephropathy. (1987) (19)
AIDS/HIV: Finding Footprints Among the Trees (2007) (18)
New ways of causal pathways thinking for public health (2002) (18)
HIV-1 Conserved Mosaics Delivered by Regimens with Integration-Deficient DC-Targeting Lentiviral Vector Induce Robust T Cells (2017) (18)
HLA restriction of human cytotoxic T cells (1980) (18)
Quantitative and Qualitative Differences in the T Cell Response to HIV in Uninfected Ugandans Exposed or Unexposed to HIV-Infected Partners (2013) (18)
M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenza. (2017) (18)
Detailed and atypical HLA-E peptide binding motifs revealed by a novel peptide exchange binding assay (2020) (18)
A method for producing monoclonal antibodies to human T-cell-receptor beta-chain variable regions. (1993) (17)
Cytotoxic T lymphocyte epitopes shared between HIV-1, HIV-2, and SIV. (1993) (17)
Preferential detection of HIV subtype C' over subtype A in cervical cells from a dually infected woman. (2005) (17)
Multiple Sclerosis and Ultraviolet Radiation: Time to Shed More Light (2001) (17)
Another HIV vaccine failure: where to next? (2013) (17)
25 years of HIV research on virology, virus restriction, immunopathogenesis, genes and vaccines (2008) (17)
Interleukin-10 responses to therapeutic vaccination during highly active antiretroviral therapy and after analytical therapy interruption (2009) (16)
Use of high dose X-irradiation to block back stimulation in the MLC reaction. (2008) (16)
HLA class I antigens in severe RSV bronchiolitis. (1989) (16)
Selection of T cell receptor variable gene‐encoded amino acids on the third binding site loop: a factor influencing variable chain selection in a T cell response (1995) (16)
Cytotoxic T-cell antagonism in HIV-1 (1996) (16)
CORRIGENDUM: Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis (2005) (16)
Lysis of allogeneic human lymphocytes by nonspecifically activated T‐like cells (1982) (16)
The UK Register of HIV Seroconverters: methods and analytical issues (1996) (16)
Cytotoxic T lymphocytes and immune surveillance. (1992) (16)
Proof-of-Principle for Immune Control of Global HIV-1 Reactivation In Vivo (2015) (16)
Author Correction: Progression of whole-blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in severe influenza (2019) (15)
Antibody-targeted MHC complex-directed expansion of HIV-1- and KSHV-specific CD8+ lymphocytes: a new approach to therapeutic vaccination. (2004) (15)
HIV: Bad news for stop–start therapy? (2002) (15)
Functional analysis of dendritic cell–T cell interaction in sarcoidosis (2010) (15)
Fitness costs and diversity of CTL response determine the rate of CTL escape during the acute and chronic phases of HIV infection (105.23) (2011) (15)
Antigen presentation in virus infection. (1992) (15)
An epidemiological study of the mental health of Australian university students. (1974) (15)
Antigen presentation in virus infection (1992) (15)
A competitive radioimmunoassay using a monoclonal antibody to detect the factor X activator of Russell's viper venom. (1987) (15)
Effects of retroviral protease inhibitors on proteasome function and processing of HIV-derived MHC class I-restricted cytotoxic T lymphocyte epitopes. (2001) (15)
Clones of B lymphocytes: their natural selection and expansion. (1976) (15)
Natural selection at work on the surface of virus-infected cells. (1993) (14)
Abnormalities in iNKT cells are associated with impaired ability of monocytes to produce IL‐10 and suppress T‐cell proliferation in sarcoidosis (2014) (14)
Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies (2022) (14)
Occupational exposure and risk of central nervous system demyelination. (2013) (14)
T-cell-targeted immunotherapy. (1992) (14)
Climate change and stratospheric ozone depletion. Early effects on our health in Europe. (2000) (14)
Climate change and health: Risks and Inequities (2011) (14)
Stratospheric ozone depletion, ultraviolet radiation and health (2003) (14)
P17-28 LB. The antiviral efficacy of HIV-specific CD8+ T-cells to a conserved epitope is heavily dependent on the infecting HIV-1 isolate (2009) (13)
Phenotypic analysis of antigen-specific T lymphocytes. Science. 1996. 274: 94-96. (2011) (13)
Preexisting compensatory amino acids compromise fitness costs of a HIV-1 T cell escape mutation (2014) (13)
Environmentally Sustainable and Equitable Meat Consumption in a Climate Change World (2010) (13)
Comparison of Neutralizing Antibody Responses Elicited from Highly Diverse Polyvalent Heterotrimeric HIV-1 gp140 Cocktail Immunogens versus a Monovalent Counterpart in Rhesus Macaques (2014) (13)
Climate-Related Displacement: Health Risks and Responses (2010) (13)
The HIV protease inhibitor Indinavir reduces immature dendritic cell transendothelial migration (2003) (13)
Alternative Spliced CD1D Transcripts in Human Bronchial Epithelial Cells (2011) (12)
Improved detection of latent Mycobacterium tuberculosis infection in HIV‐1 seropositive individuals using cultured cellular assays (2011) (12)
Identification of the viral molecules recognised by influenza specific human cytoxic T lymphocytes. (1987) (12)
Capturing the antigen landscape: HLA-E, CD1 and MR1. (2019) (12)
Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro. (2000) (12)
Is a Human CD8 T-Cell Vaccine Possible, and if So, What Would It Take? Could a CD8+ T-Cell Vaccine Prevent Persistent HIV Infection? (2018) (12)
Innate immune responses in acute HIV-1 infection: protective or pathogenic? (2013) (12)
Cytotoxic T lymphocytes: specificity, surveillance, and escape. (1992) (12)
Class I Major Histocompatibility Complex-restricted Cytotoxic T Lymphocytes Specific for Epstein-Barr Virus (EBV) Nuclear Antigens Fail to Lyse the EBV-transformed B Lymphoblastoid Cell Lines (2003) (12)
How does the HIV escape cytotoxic T cell immunity? (1993) (12)
Unusual antigen presentation offers new insight into HIV vaccine design. (2017) (12)
Erratum: HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women (Nature Medicine 1, 59-64, (1995)) (1995) (11)
Oral cancer in the Third World: time for preventive intervention? (1984) (11)
T cell receptor usage in infectious disease (2004) (11)
Facts at your fingertips (1993) (11)
Reversion and T Cell Escape Mutations Compensate the Fitness Loss of a CD8+ T Cell Escape Mutant in Their Cognate Transmitted/Founder Virus (2014) (11)
NON-STATIONARY INFLUENCE OF EL NI??O ON THE SYNCHRONOUS DENGUE EPIDEMICS IN THAILAND (2005) (11)
Contemplating a one child world (1995) (11)
Expansion of HIV-1-specific CD28- CD45RA- CD8+ T cells in chronically HIV-1-infected individuals. (2000) (11)
Editorial: Globalisation, environmental change and health (2000) (11)
Clonal dominance and the preservation of clonal memory cells mediated by antigen-antibody. (1976) (11)
Templates for a vaccine (2010) (11)
Prostitutes in Nairobi Responses in the Cervix of HIV-1-Resistant Lymphocyte + HIV-1-Specific Mucosal CD 8 (2000) (11)
Clonal memory. I. Time-course of proliferation of B-memory cells. (1974) (11)
The Future of Public Health in a Changing Global Context (1999) (11)
An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease (2021) (11)
A cross‐species functional interaction between the murine major histocompatibility complex class I α3 domain and human CD8 revealed by peptide‐specific cytotoxic T lymphocytes (1992) (11)
Bovine spongiform encephalopathy: its wider meaning for population health (1996) (11)
HIV. The immune response. (1996) (10)
Methods to assess the effects of climate change on health (2001) (10)
The Port Pirie Cohort Study — Cumulative Lead Exposure and Neurodevelopmental Status at Age 2 Years: Do HOME Scores and Maternal IQ Reduce Apparent Effects of Lead on Bayley Mental Scores? (1989) (10)
Isolation of HIV-1-specific cytotoxic T lymphocytes using human leukocyte antigen-coated beads. (1999) (10)
Characterization of the HLA-A2.2 subtype: T cell evidence for further heterogeneity (2004) (10)
Altered primary CD8+ T cell response to a modified virus Ankara(MVA)‐vectored vaccine in the absence of CD4+ T cell help (2005) (10)
Functional Differences Exist between TNFα Promoters Encoding the Common −237G SNP and the Rarer HLA-B*5701-Linked A Variant (2012) (10)
The immune response to diphtheria toxoid in humans. (1977) (10)
Letter to the Editor: 1H, 13C, and 15N Resonance Assignments of Human Notch-1 Calcium Binding EGF Domains 11-13 (2004) (10)
Patterns of help-seeking for mental illness among Australian university students: an epidemiological study. (1974) (10)
Climate change and health: information to counter the White House Effect. (2001) (10)
Correction: Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine (2011) (10)
Generation and characterisation of CD1d tetramer produced by a lentiviral expression system. (2008) (10)
The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. 1986. (2006) (10)
The presence of prolines in the flanking region of an immunodominant HIV‐2 gag epitope influences the quality and quantity of the epitope generated (2015) (9)
Engagement of a T cell receptor by major histocompatibility complex irrespective of peptide (1997) (9)
A cluster of mutations in HLA-A2 α2 helix abolishes peptide recognition by T cells (2004) (9)
A mAb against HLA-A2 can be influenced both positively and negatively by the associated peptide. (1995) (9)
Expression and function of HLA‐B27 in lipid‐linked form: Implications for cytotoxic T lymphocyte‐induced apoptosis signal transduction (1993) (9)
An HLA-D specificity found in the Japanese population. (2008) (9)
Strategies for an HIV cure: progress and challenges (2018) (9)
Reflecting on a quarter century of HIV research (2008) (9)
High Level Antibody Response to Pandemic Influenza H1N1/09 Virus Is Associated With Interferon-Induced Transmembrane Protein-3 rs12252-CC in Young Adults (2018) (8)
Radioactive antigen suicide of an anti‐DNP (2,4‐dinitrophenyl) clone. I. Recovery and escape from clonal dominance by suici resistant precursors (1975) (8)
The association of vinyl chloride exposures with morbidity symptoms. (1975) (8)
Why the long latent period? (1990) (8)
Dioxins in Belgian feed and food: chickens and eggs. (1999) (8)
Globalisation and environmental change: implications for health and health inequalities (2001) (8)
HLA B27: a disease-associated immune response gene. (1991) (8)
Involvement of the 4-1BB/4-1BBL Pathway in Control of Monocyte Numbers by Invariant NKT Cells (2014) (8)
Regulation of Immune Gene Expression (1986) (8)
Immunotherapy with Antibody-Targeted HLA Class I Complexes: Results of in vivo Tumour Cell Killing and Therapeutic Vaccination (2007) (8)
The Psychological Health of University Students as Measured by a Personality Inventory* (1973) (8)
B-cell or T-cell immunity? (1982) (8)
HLA, malaria and dominant protective associations. (1992) (8)
Time trends in upper alimentary tract cancer rates and alcohol and tobacco consumption in Australia. (2010) (8)
Immunogenicity of a universal HIV-1 vaccine vectored by DNA, MVA and CHADV-63 in a Phase I/IIA clinical trial (2012) (8)
Specific recognition of influenza virus polymerase protein (PB1) by a murine cytotoxic T-cell clone. (1987) (8)
The effect of environmental change on food production, human nutrition and health (2005) (7)
How viruses hide from T cells. (1997) (7)
Contrasting views on human population growth (1999) (7)
T-cell receptors: on the track of Tau? (1983) (7)
Identification of a novel HLA-B*3501-restricted cytotoxic T lymphocyte epitope using overlapping peptides. (1997) (7)
Vegetarians and longevity: imagining a wider reference population. (1992) (7)
Immunology: HLA class II antigens and monoclonal antibodies (1983) (7)
Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity (2020) (7)
Breast cancer in Australia (1988) (7)
Comparison of Sexual Behavior and HIV Risk between Two HIV-1 Serodiscordant Couple Cohorts: The CHAVI 002 Study (2012) (7)
Specificity of Cytotoxic T Lymphocytes Stimulated with Influenza Virus (Part 2 of 2) (1985) (7)
Population health: where demography, environment and equity converge. (2010) (7)
The Relationship between Social Stress, Adolescence and Mental Health among University Students* (1974) (7)
Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides (2022) (7)
Alimentary tract cancer in Australia in relation to diet and alcohol (1979) (7)
B MEMORY CELLS IN THE PROPOGATION OF STABLE CLONES OF ANTIBODY FORMING CELLS (1974) (7)
Dysfunctional Epstein-Barr virus ( EBV )-specific CD 8 ( + ) T lymphocytes and increased EBV load in HIV-1 infected individuals (2001) (7)
Effects of monoclonal antibodies to the alpha and beta chains of the human lymphocyte function-associated (H-LFA-1) antigen on T lymphocyte functions. (1985) (7)
International study of temperature and heatwaves on urban mortality in low & middle income countries (isothurm) (2002) (6)
Human naive CD 8 T cells downregulate expression of the WNT pathway transcription factors lymphoid enhancer binding factor 1 and transcription factor 7 ( T cell factor-1 ) following antigen encounter in vitro and in vivo (2018) (6)
Environmental change, climate, and health (2013) (6)
Assessment of the global burden of disease attributable to climate change (2001) (6)
Topological perspective on HIV escape (2019) (6)
Recognition of influenza A virus by human cytotoxic T lymphocytes. (1989) (6)
A Novel Approach to Antigen-Specific Deletion of CTL with Minimal Cellular Activation Using a 3 Domain Mutants of MHC Class I / Peptide Complex express (2001) (6)
Complexity in human histocompatibility loci (1981) (6)
Conceptual and methodological challenges in predicting the health impacts of climate change. (1995) (6)
How soon after HIV seroconversion is antiretroviral therapy initiated? The UK Register of HIV Seroconverters Steering Committee. (1999) (6)
Crystal structureof the complexbetweenhuman CD 8 aa andHLA-A 2 (1997) (6)
Chronic respiratory symptoms and job type within the rubber industry. (1976) (6)
Host Genetics and Viral Diversity: Report from a Global HIV Vaccine Enterprise Working Group (2010) (6)
Climate change and human health: mapping and modelling potential impacts (2000) (5)
Erratum: Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals (Journal of Clinical Investigation (2008) 118, 10, (3478-3490) doi:10.1172/JCI32460) (2012) (5)
Nosing ahead in the cold war (1990) (5)
HIV: T cell responses to HIV: Editorial overview (2000) (5)
Teratogenic effect of extended administration of N-nitrosoethylurea and ethylurea/nitrite in rats. (1983) (5)
A Plea for Justice for Jailed Medical Workers (2006) (5)
Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events (2012) (5)
Legacy of the influenza pandemic 1918: The host T cell response (2018) (5)
Global environmental changes: anticipating and assessing the risks to health (2002) (5)
A cluster of mutations in HLA-A2 alpha 2 helix abolishes peptide recognition by T cells. (1991) (5)
Mallory bodies inalcoholic liver disease: identification ofcytoplasmic filament/cell membrane andunique antigenic determinants bymonoclonal antibodies (1981) (5)
Relevance of high and low penetrance (2001) (5)
Maternal smoking and childhood respiratory illnesses: A seven year cohort study (1991) (5)
Population and Reproductive Rights: Feminist Perspectives from the South (1995) (5)
Emergence of a distinct HIV‐specific IL‐10‐producing CD8+ T‐cell subset with immunomodulatory functions during chronic HIV‐1 infection (2013) (5)
Cytotoxic T lymphocytes specific for murine type II collagen do not trigger arthritis in B10 mice (1996) (5)
The Urban Environment and Health (2008) (5)
Global environmental changes and human health (2002) (5)
Safety and immunogenicity of DNA and MVA HIVA vaccines in Phase-1 vaccine trials in Nairobi, Kenya (2004) (4)
HIV vaccines: The myth of cross-reactive T cells (2003) (4)
Latitudinal variation in incidence of first demyclinating events: descriptive analyses of case participants in the Ausimmune Study (2008) (4)
Introduction: Presentation of viral antigens to cytotoxic T cells (1996) (4)
HIV-gag-specific cytotoxic T lymphocytes. (1989) (4)
HIV Preparing for HIV vaccines that induce cytotoxic T lymphocytes (1998) (4)
Prolonged CD8+ T-cell expansions after adoptive transfer of syngeneic lymphocytes between HIV-discordant identical twins. (1998) (4)
Colorectal cancer. (1994) (4)
Interrogating the recognition landscape of a conserved HIV-specific TCR reveals distinct bacterial peptide cross-reactivity (2020) (4)
T‐Cell Receptor Usage of Major Histocompatibility Complex Class I Restricted Peptide‐Specific T‐Lymphocytes (1995) (4)
Climate change and stratospheric ozone depletion (2001) (4)
Recognition of viral antigens at the cell surface. (1995) (4)
Erratum: Dynamics of T cell responses in HIV infection (The Journal of Immunology (2002) 168 (3660-3666)) (2002) (4)
Mature CD 8 + T lymphocyte response to viral infection during fetal life (2018) (4)
Influenza vaccines: mTOR inhibition surprisingly leads to protection (2013) (4)
Interrelationships between dietary intake, dietary knowledge and coronary heart disease risk factors in a group of undergraduate students. (1980) (4)
Cairo conference (1994) (4)
Planetary stewardship in an urbanizing world (2012) (4)
PORT PINE COHORT STUDY: ENVIRONMENTAL EXPOSURE TO LEAD AND CHILDREN'S AT THE AGE OF FOUR YEARS (1988) (4)
Correction: Copy Number Variation of KIR Genes Influences HIV-1 Control (2011) (4)
High clade C HIV-1 viremia: how did we get here and where are we going? (2011) (4)
Plasma membranes from influenza virus-infected cells induce in vitro human secondary virus-specific cytotoxic T lymphocyte responses. (1983) (3)
Specificity of Cytotoxic T Lymphocytes Stimulated with Influenza Virus (Part 1 of 2) (1985) (3)
A strongly selected mutation in the HIV-1 genome is independent of T cell responses and neutralizing antibodies (2017) (3)
Global environmental change and child health. (2005) (3)
Recognition of the Viral Nucleoprotein by Influenza a Specific Cytotoxic T Cells (1985) (3)
From influenza to HIV—and back? (2007) (3)
The immune response to HIV (2005) (3)
Global Climate Change and Health: Research Challenges, Ecological Concepts and Sustainability (2001) (3)
T-cell strategies in AIDS vaccines (1989) (3)
Climate change and child health in Australia: Likely futures, new inequalities? (2010) (3)
NKT Cells Controls T Cell Expansion Subset of CD 1 d-Restricted αα CD 8 − CD 4 and (2004) (3)
The global burden of disease due to UVR exposure (2006) (3)
Inhibition of Virus-Specific, HLA-Restricted, T Cell-Mediated Lysis by Monoclonal Anti-T Cell Antibodies (1984) (3)
Future vaccines for HIV (1996) (3)
Lymphocytes. 1. Function. Genetic restrictions in the immune response. (1979) (3)
EVALUATION OF QUESTIONNAIRE METHODS OF MEASUREMENT OF ALCOHOL CONSUMPTION IN YOUNG AUSTRALIANS (2010) (3)
Structural relationship between HLA-A2-restricted and anti-A2 allospecific T-cell recognition: analysis by mutation of the codons for polymorphic and conserved residues. (1991) (3)
Antisense-Derived HIV-1 Cryptic Epitopes Are Not Major Drivers of Viral Evolution during the Acute Phase of Infection (2018) (3)
12. Ecological studies (1997) (3)
Detection of broad functional gag-specific CD4+ T cell responses in HIV-1-infected subjects following therapeutic immunization with rMVA expressing an HIV-1 gag immunogen (2006) (3)
P01-01. The blood transcriptional response to early acute HIV infection is transient and responsive to antiretroviral therapy (2009) (3)
General introduction to the MHC (1995) (3)
Global climate change and infectious diseases: paradigms, impacts and future challenges (2009) (3)
Generation of tumour-rejecting anti-carbohydrate monoclonal antibodies using melanoma modified with Fas ligand. (2008) (3)
Development of a Universal T Cell Vaccine (2008) (3)
Global Climate Change and Human Health (2009) (3)
Environmental lead and intellectual development: strengths and limitations of epidemiological research. (1995) (2)
Antigen Processing Takes a New Direction (2013) (2)
Expression of unusual HLA class I on human extravillous trophoblast and a choriocarcinoma cell line (1989) (2)
Evidence that the Monoclonal Antibody an 51 is Directed Against Platelet Membrane Glycoprotein IB (1983) (2)
P16-23. Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance (2009) (2)
Identification of a human Ia antigen that is different from HLA-DR and DC antigens (2004) (2)
Functional characterisation of HLA-B27 in autoimmunity (2001) (2)
A NEW LOOK AT TUMOR IMMUNOLOGY - INTRODUCTION (1992) (2)
The need to consider age and anatomic subsite when comparing sex-specific survival rates for colorectal cancer. (1982) (2)
Rethinking environment and health (2001) (2)
Infectious Diseases in an Age of Change. (1996) (2)
HIV-1 Vaccine Development (2015) (2)
Magnitude of Alloresponses to MHC Class I/II Expressing Human Cardiac Myocytes is Limited by their Intrinsic Ability to Process and Present Antigenic Peptides (2003) (2)
In pursuit of an HIV vaccine: an interview with Andrew McMichael (2013) (2)
Human Health in a Changing Climate: Past, Present, and Future (2006) (2)
Ita Askonas and her influence in the field of antigen presentation. (2014) (2)
EPITOPE VARIATION AND T-CELL RECOGNITION (1995) (2)
Ultraviolet radiation and organ-specific auto-immune disease: insights form epidemiological research (2002) (2)
Preferential Expression of the Human Vβ7.1 Gene Segment on CD8+ Peripheral Blood Lymphocytes (1995) (2)
HLA allele distributions and associations in a cohort of LTNPs from China (2011) (2)
HLA-E restricted, HIV-1 suppressing, Gag specific CD8+ T cells offer universal vaccine opportunities (2020) (2)
Association between actinic damage, a biomarker of lifetime sun exposure, and first clinical diagnosis of central nervous system demyelination: the Ausimmune Study (2008) (2)
Characterization of a novel HLA-A2 variant, A*0214, by ARMS-PCR and DNA sequencing (2004) (2)
Binding and Functional Analysis of the Workshop T Cell Specific Set of Monoclonal Antibodies (1986) (2)
Contrasting views on human population growth (1999) (2)
Smoking Kills: The Revolutionary Life of Richard Doll. Conrad Keating. (2010) (2)
HLA B27 can form heavy chain homodimers in vivo and in vivo, possible role of cys 67. (1998) (2)
The Role of Cytotoxic T Lymphocytes in Protection Against HIV Infection and AIDS (2002) (2)
Inheritance of an isoelectrically focused spectrotype linked to theIg-1b allotype (1975) (2)
INTERACTIONS BETWEEN PEPTIDE AND CLASS-I MHC - IMPLICATIONS FOR IMMUNOTHERAPY IN RHEUMATIC DISEASE (1993) (2)
The Importance of Cellular Immune Response to HIV: Implications for Antibody Production and Vaccine Design (2021) (2)
Epidemiology and the People's Health. Theory and Context.Nancy Krieger. (2011) (2)
Stratospheric ozone depletion: successful responses to a global environmental insult (2005) (2)
Population and the Environment: The Linacre Lectures 1993-4 (1997) (2)
Primary and secondary functions of HLA-E are determined by stability and conformation of the peptide-bound complexes (2022) (2)
Widening the horizons of ‘evidence’: Nutrition and disease in ecological perspective (2005) (1)
T Cell Responses Minireview and Viral Escape (1998) (1)
HLA correlates in a cohort of slow progressors from China: effects on HIV-1 disease progression (2013) (1)
Fatness and thinness (2001) (1)
Recombination-mediated escape from primary CD8+ T cells in acute HIV-1 infection (2014) (1)
InfectionDistinguishes HIV-2 from HIV-1 Maintenance of HIV-Specific CD4+ T Cell (2013) (1)
RECOMMENDATIONS ON METHODS OF MEASURING ALCOHOL CONSUMPTION (2010) (1)
TIME TRENDS IN UPPER ALIMENTARY TRACT CANCER MORTALITY AND ALCOHOL CONSUMPTION IN AUSTRALIA (2010) (1)
HLA-B27-RESTRICTED PEPTIDE PRESENTATION TO CYTOTOXIC T-CELLS IN REACTIVE ARTHRITIS (1995) (1)
Suboptimal?Fever: Are Cross-Reactive T Cells T Cell Responses in Dengue Hemorrhagic (2006) (1)
Erratum: Lessons learned from HIV-1 vaccine trials: new priorities and directions (2013) (1)
Environment as a global public good for health (Chapter 5) (2003) (1)
Ankylosing spondylitis without B27: no evidence for gene conversion. (1988) (1)
Emergency Hospital Admissions of Cardiovascular Disease and Heart Failure in 3 Australian Cities: Are They Associated With Climatic Factors? (2006) (1)
Climate Change and Global Public Health (2010) (1)
T-CELL RECEPTOR USAGE OF SYNOVIAL LYMPHOCYTES FROM A PATIENT WITH REACTIVE ARTHRITIS (1992) (1)
Diet, nutrition and disease. Contemporary Australian epidemiology. (1985) (1)
Phagocytic uptake of transmitted/founder virus-infected CD4+T cells enhances macrophage infection (2012) (1)
Immune signature atlas of vaccines: learning from the good responders. (2022) (1)
Antigen-sensitive CD8 T-cell clones with tough HIV-1 suppression (2013) (1)
HLA-Ebindstonatural killer cell receptors CD 94 / NKG 2 A , BandC (1)
Interferon-gamma Responses to HIV-1 Clade A and D Peptides in Ugandan Serodiscordant Couples - the CHAVI 002 Protocol (2008) (1)
Definition of Polymorphism Within DR2-Associated DQw1 Molecules (1989) (1)
Mutants of HLA-A2 in the analysis of its structure and function. (1989) (1)
Simplification of two-dimensional gel patterns of HLA class II antigens. (2008) (1)
Identification of a novel HLA-A2 subtype, HLA-A*0216 (2004) (1)
Deficiency of CD1D restricted NKT cells may contribute to dysregulated T cell proliferation in sarcoidosis (2003) (1)
AGGREGATION OF RANTES IS RESPONSIBLE FOR THE ACTIVATION OF LEUKOCYTES (1999) (1)
Alan Williams 1945–1992 (1992) (1)
GIMAP6 regulates autophagy, immune competence, and inflammation in mice and humans (2022) (1)
Preexisting compensatory amino acids compromise fitness costs of a HIV-1 T cell escape mutation (2014) (1)
GENE SET ANALYSIS OF LUNG SAMPLES FROM PROGRESSIVE, FIBROTIC PULMONARY SARCOIDOSIS SHOWS A PATTERN SIMILAR TO HYPERSENSITIVITY PNEUMONITIS (2009) (1)
The Environment and Human Health (2005) (1)
A phase 1 clinical study of the safety, toxicity, and immunogenicity of the Ty, p24, VLP in healthy volunteers. Interim report (1992) (1)
HIV-2 gene product-specific T cell responses and viraemia control (2006) (1)
Dynamics of T Cell Responses in HIV (2013) (1)
The global environment (2009) (1)
Recombinant DNA/MVA/ChAdV-63-elicited T cells specific for conserved regions of the HIV-1 proteome recognize HIV-1 infected cells and suppress HIV-1 (2012) (1)
Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial (2021) (1)
Winter mortality in the elderly in Great Britain: A socio- economic paradox? (2003) (1)
Modulation of chemokine receptor expression on CLA+ T cells in atopic dermatitis (2004) (1)
Identification and characterisation of cell surface HLA-B27 homodimers (2002) (1)
Conflicting selective forces affect CD8 T-cell receptor contact sites in an HLA-A2 immunodominant HIV epitope. (2006) (1)
Lower vitamin D status at first clinical diagnosis of central nervous system demyelination compared to matched controls (2009) (1)
Climate Change and Global Public Health: Impacts, Research and Actions (2011) (1)
Analysis of the T Cell-Specific Sets of Monoclonal Antibodies (1984) (1)
Life-long vegetarianism and risk of breast cancer: a population-based case-control study among South Asian migrant women living in England. Abstract of the International Epidemiological Association (2001) (1)
Subdivision of Haplotype HLA-DR3 by Biochemical and Functional Analysis (1989) (1)
ANTIGEN DEPENDANCE OF CLONAL MEMORY (1974) (1)
Erratum: Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction (Journal of General Virology (2007) vol. 88 ( 1) (1-12)) (2008) (1)
Climate Change and Health in Cambodia: Vulnerability and Adaptation Assessment. (2010) (1)
In pursuit of an HIV vaccine: an interview with Andrew McMichael (2013) (1)
CLONAL MEMORY (1974) (1)
HLA-B27 transgenic rodents express cell surface HLA-B27 heavy chain homodimers and multimers. (2003) (1)
Methodological issues in assessing the effects of climate change on health (2001) (1)
HIV-1 vaccines: let's get physical. (2013) (1)
NMR structure of the human NOTCH-1 ligand binding region (2004) (1)
The challenges of an HIV vaccine enterprise - Response (2004) (1)
Climate change and human Health: issues for teacher and classroom (2010) (1)
High pro-inflammatory cytokine secretion and selective depletion of high avidity cross-reactive cytotoxic T-cells in the pathogenesis of acute secondary dengue virus infection (2007) (0)
DNA- and MVA-based multi-CTL epitope vaccines for HIV and Plasmodium falciparum: Immunogenicity in mice and macaques (1997) (0)
Repertoire sharing between CD4(+) T follicular helper cells in peripheral blood and tonsil (2019) (0)
Letters to the Editor (1987) (0)
Author Correction: Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding (2018) (0)
Society for Social Medicine and the International Epidemiological Association European Group (2001) (0)
HLA COMPLEX AND THE IMMUNE-RESPONSE TO INFLUENZA-VIRUS (1978) (0)
Cytotoxic T-cell abundance and virus load in human immunode ciency virus type 1 and human T-cell leukaemia virus type 1 (2001) (0)
A Weather-Based Predictive Model for Barmah Forest Virus Disease in Brisbane, Australia (2006) (0)
Germs, genes and greenhouse gases: the changing landscape of population health: Faculty of Public Health Medicine Queen Elizabeth the Queen Mother Lecture, 2000 (2001) (0)
I. TIn-E-CouRSE OF PROLIFEP~TION oF B-MEMORY CELLS (1974) (0)
HLA-E*01:03 in complex with the Mtb44 peptide variant: Mtb44*P2-Phe. (2018) (0)
GLOBAL ENVIRONMENTAL CHANGE AND HUMAN HEALTH: OVERLOADING THE SYSTEM - AND THE SCIENCE?: K 145 (1996) (0)
Natural altered peptide ligands in HIV infection (1996) (0)
The Role of Cytotoxic Lymphocytes in HIV Infection (1992) (0)
Environmental Epidemiology : Origins, Current Status and Future Challenges (1995) (0)
The CD8+T cell antiviral inhibitory activity predicts the rate of CD4+cell decline in early HIV-1 infection and is independent of viral subtype (2011) (0)
Lipid Binding: A Necessary Evil for Broadly Neutralizing Anti-gp41 Antibodies? (2008) (0)
Genes and Common Diseases: Environment and disease (2007) (0)
Lung Immunology and HIV (1997) (0)
Invariant NKT cells are required for a proportionate innate immune response to highly pathogenic influenza A virus infection (2008) (0)
Vaccine for Specific Targets: HIV (2004) (0)
HLA-E*01:03 in complex with the HIV epitope, RL9HIV (2018) (0)
Viral peptides that interact with HLA-A2 inhibit cytotoxic T cell activity (1988) (0)
A DOLLAR'S WORTH OF HEALTH (1977) (0)
Anti-CD8 antibody induced transcriptional remodelling in HIV-specific CD8 T cells secreting Anti-HIV-1 factors (2004) (0)
MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE TPYDINQML FROM GAG PROTEIN OF HIV2 (1998) (0)
GENES CODING FOR ANTIBODIES (1975) (0)
HLA RESTRICTION OF CYTOTOXICITY AGAINST INFLUENZA-INFECTED HUMAN CELLS (1979) (0)
Environmental causes of human birth defects (1991) (0)
antibody . disease using a monoclonal HLA ( A , B , C ) antigens in liver Immunohistochemical analysis of (0)
Escafe from immune control by HIV (1997) (0)
Book review (1998) (0)
ST111 Immune selection and vpu variability in a unique narrow source HIV-Positive village cohort (2013) (0)
An epidemiologic perspective on the identification of workers at risk. (1975) (0)
Predictive accuracy of different clinical definitions of influenza in the community setting (2008) (0)
CD8+ T cell inhibitory activity and targeting of beneficial regions and conserved elements within the HIV proteome. (2015) (0)
Regulation of Antigen Presentation and T Cell Subsets (1986) (0)
Never ending circuits (1985) (0)
Recognition of Carbohydrate by Major Histocompatibility Complex Class 1-restricted, Glyeopeptide-specific (2003) (0)
Re-evaluating the peptide repertoire of MHC-E (2017) (0)
Initial HIV-1 Antigen-Speciﬁc CD8 (cid:1) T Cells in Acute HIV-1 Infection Inhibit Transmitted/Founder Virus Replication (2012) (0)
FACULTY OF HEALTH SCIENCES UCT (2011) (0)
Lead and child development. (1993) (0)
Overview of Heterologous Prime-Boost Immunization Strategies (2009) (0)
Quantitative Estimation and Prediction of Risk at the International Agency for Research on Cancer (1994) (0)
InfectionDynamics of T Cell Responses in HIV (0)
MECHANISM OF MHC-MEDIATED ANTIGEN RECOGNITION BY T-CELLS (1993) (0)
Climate variability and Ross River virus in 8 Australian cities, 1985-1996 (2001) (0)
Methods and reagents for production of a CD8 + T cell immune response against Melanoma (1998) (0)
Brigitte Alice Askonas. 1 April 1923—9 January 2013 (2018) (0)
Using Epidemiology as a Tool to Study Environmental Health (2012) (0)
Variant and Mutant HLA-A2 Molecules Affect Recognition of Influenza Matrix Peptide 56–68 by Cytotoxic T Lymphocytes (1989) (0)
DEVELOPMENT OF A SYSTEM OF EXPRESSION CLONING FOR MOLECULES COSTIMULATORY FOR T-CELLS (1994) (0)
Cohort profile Cohort Profile: The Flu Watch Study the Flu Watch Group (2016) (0)
The role of Hiv specific Ctl in Hiv infection (1993) (0)
Virus Cell Response to Infection with a Persistent Clonal Succession : The Evolution of the T Clonal Selection , Clonal Senescence , and and (2002) (0)
Vaccinia virus strain modified virus Ankara: Characterisation of cytokine receptor profile, virological features, and use as an immunological reagent (1997) (0)
Antiretroviral Therapy Driven by Vaccination during Highly Active T Cell Expansions + HIV-1-Specific CD8 Broad TCR Usage in Functional (2007) (0)
HLA-E-presented peptides as novel targets for HIV-1 therapy (2019) (0)
CD1d/NKT cells (PP-006) (2010) (0)
Climate change and the human immune system: Ultraviolet radiation & immunity study, assessing the impact of ultraviolet radiation on the immune response to primary vaccination in Australian adults (2009) (0)
Function Genetic restrictions in the immune response (2006) (0)
Discovery of HLA-E-Presented Epitopes: MHC-E/Peptide Binding and T-Cell Recognition. (2022) (0)
Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding (2018) (0)
Transgenic Mice T Cell Responses in TCR + as well as CD8 + Fully Functional HLA B27-Restricted CD4 (2003) (0)
Encounter In Vitro and In Vivo (T Cell Factor-1) following Antigen Binding Factor 1 and Transcription Factor 7 Transcription Factors Lymphoid Enhancer Expression of the WNT Pathway Human Naive CD8 T Cells Down-Regulate (2006) (0)
Passive smoking (1987) (0)
Where we stand: A surprising look at the real state of our planet, Seymour Garte. Amacom, New York (2008), 290 pp. (hardback) (2008) (0)
Mapping the epitopes of the Human Leukocyte Antigen E antibodies 3D12 and 4D12 (2022) (0)
Estimated millions at risk: Climate change without sustainable development (2001) (0)
HLA-E*01:03 in complex with Mtb44 (2018) (0)
Differences in HIV-Speciﬁc T Cell Responses between HIV-Exposed and -Unexposed HIV-Seronegative Individuals (cid:1) † (2011) (0)
Lack of truncated IFITM3 transcripts in cells homozygous for the rs12252-C variant infection (2017) (0)
P16-42. Characterisation of HIV-1 specific T-cell responses in exposed uninfected individuals from a London cohort (2009) (0)
Running title: HLA -A2 monomers stimulate WT1 -specifc CTL (2004) (0)
CHARACTERIZATION OF BLAST CELLS BY ULTRASTRUCTURAL CYTO-CHEMISTRY AND MONOCLONAL-ANTIBODIES (1983) (0)
Analysis of H5N1 specific T cell responses in a high risk cohort in VietNam indicates possible asymptomatic infection (2010) (0)
Legacy of the inﬂuenza pandemic 1918: The host T cell response (0)
SKIN CANCER AND ULTRAVIOLET. AUTHORS' REPLY (1994) (0)
IDENTIFYING A GENE EXPRESSION SIGNATURE FOR PROGRESSIVE PULMONARY SARCOIDOSIS (2008) (0)
Construction of chimaeric haemagglutinin genes in order to investigate determinants for recognition by murine cytotoxic T cells (1985) (0)
The politics of emerging and resurgent infectious diseases (2001) (0)
Environment and disease (2007) (0)
DNA-Modified Virus Ankara and Other Heterologous Prime-Boost Immunization Strategies for Effector T Cell Induction (2004) (0)
HIV preventive vaccines (2007) (0)
Peripheral Fibroblasts into CD56dim Cells: Role of Contact with CD56bright Human NK Cells Differentiate (2013) (0)
Decision letter: mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status (2021) (0)
Rapid preparation of B-cell-enriched lymphocytes by electrophoresis. (1977) (0)
Methods and reagents for production of a CD8 + T cell immune response to hepatitis B or C (1998) (0)
2.8 The global environment (2009) (0)
Intracellular trafficking of HLA-E and its regulation. (2023) (0)
Potential role for CD1d restricted T-cells in the immunopathology of sarcoidosis (2003) (0)
Low IL-10 production by der p 1-specific T cells in severe atopic dermatitis (2003) (0)
Subversion of immune responses (1993) (0)
Temperature-mortality relation in twelve cities of the world [Relation temprature-mortalit dans douze villes du monde] (2009) (0)
HOMOCYSTEINE AND HLA B27-ASSOCIATED ARTHROPATHIES (1995) (0)
The Role of T Cell Immunity in the Control of HIV Infection (2010) (0)
Functional analysis of candidate CD8+T cell-derived anti-HIV factors (2005) (0)
Induction of Fas Ligand Expression by HIV Involves the Interaction of Nef with the T Cell Receptor (cid:122) Chain By (1999) (0)
The relationship between social stesss, adolescence and mental health among university students. (1974) (0)
Relevance of high and low penetrance - Reply (2001) (0)
The T Lymphocyte Response to HIV: Molecular Basis for Immune Recognition and Escape (1993) (0)
Infection T Cell Responses during Acute HIV-1 + CD 8 and + Distinct Kinetics of Gag-Specific CD 4 and (2012) (0)
IDENTIFICATION OF T-CELL RECEPTOR RECOGNITION RESIDUES FOR AN INFLUENZA-VIRUS NONAMER PEPTIDE EPITOPE PRESENTED BY HLA B27 (1995) (0)
Multivariate linear regression models to investigate associations between beneficial responses, entropy, HLA alleles and % inhibition (dependent variable). (2015) (0)
An unbiased characterization of the HLA-E and CD94/NKG2x peptide repertoire reveals peptide ligands that skew NK cell activation (2022) (0)
Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences: 355 (1395) (2000) (0)
Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection (2018) (0)
Isolation of monoclonal antibodies targeting HLA-E/HIV-1 and SIV peptide complexes (2019) (0)
The Structure and Function of HLA-E (1999) (0)
P20-19 LB. Extensive HLA-driven viral diversity following a single-source HIV-1 outbreak in rural China (2009) (0)
Global Climate Change and Infectious Diseases: Paradigms, Impacts, and Futura Changes (2008) (0)
Memory T cell responses in influenza A infection and vaccination in humans (2012) (0)
Royal academy of medicine in Ireland international conference on homocysteine metabolism from basic science to clinical medicine (1995) (0)
Correction. The presence of prolines in the flanking region of an immunodominant HIV-2 gag epitope influences the quality and quantity of the epitope generated. (2015) (0)
Effective Antiviral CD8+T Cells Responses Are Rare in HIVPositive Step & Phambili Study Participants but Are Targeted to Low Entropy Viral Epitopes (2013) (0)
Recognition of Viral Antigens by Cytotoxic T Lymphocytes (1989) (0)
The MHC class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9 (1997) (0)
MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTY FROM THE NEF PROTEIN (75-82) OF HIV1 (1998) (0)
THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E (1999) (0)
Fully Functional HLA B27-Restricted CD4 (2003) (0)
This information is current as Vaccinia Virus Ankara Boost Regimen Vaccinated with a DNA Prime/Modified Blood Lymphocytes from Rhesus Macaques Activity in Fresh, Unstimulated Peripheral Induction of AIDS Virus-Specific CTL (2013) (0)
OA06-04. The role of early T-cell responses in subjects with acute HIV-1 infection (2009) (0)
Paired Ig-Like Receptors Models of Spondyloarthritis and Are Ligands Expressed in HLA-B 27 Transgenic Rodent HLA-B 27 Heavy Chain Homodimers Are (2004) (0)
How HIV Defeats the Immune System Author ( s ) : (2017) (0)
The kinetics and location of intra-host HIV evolution to evade cellular immunity are predictable (2016) (0)
Awards: Beit fellowships forge a Nobel link (2012) (0)
Tamarin compatibility (1990) (0)
Commentary on: "An Ecosystem Approach to Health" (Waltner-Toews D) (2001) (0)
SOCIODEMOGRAPHIC AND BEHAVIOURIAL DETERMINANTSOF BLOODLEADCONCENTRATION TO AGES ELEVEN TO THIRTEEN YEARS IN THE PORT PIRIE COHORT OF CHILDREN: T 58 (1996) (0)
Phenotypic and functional characterisation of natural killer (NK) receptor expressing T lymphocytes in spondyloarthritis (2005) (0)
Dimers are forever. Expression and recognition of abnormal HLA-B27 in spondylo arthritis (2005) (0)
NKT Cells Controls T Cell Expansion Subset of CD1d-Restricted α α CD8 - CD4 (2013) (0)
Mono clonal antibodies as a diagnostic tool in inherited disorders of platelet function (1983) (0)
Identification and characterisation of DerP1-specific CD8+T cells in the peripheral blood of atopic individuals (2002) (0)
Short title: Early cytolytic & transcriptional activity in CTLs (2016) (0)
Salt of the earth (2006) (0)
Author Correction: Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies (2023) (0)
TCR-Identical CD8+T-Cells Can Have Distinct Killing Efficacy Determined By Events Beyond the T-Cell Receptor (2017) (0)
A C Locus-Related HLA Class I Molecule on Human Trophoblast (1989) (0)
Immunology. Tamarin compatibility. (1990) (0)
P31 Immunotherapy of melanoma using antibody targeted recombinant HLA class I peptide complexes (1999) (0)
Cytotoxic T-Cells in HIV-1: "The Good" and "The Bad" (2012) (0)
Understanding the precursor frequencies of HIV-1 specific CD4+ T cells in seronegative donors (2012) (0)
How HIV Defeats the Immune System A plausible hypothesis suggests the immune devastation that underlies AIDS stems from continuous—and dangerous— evolution of the human immunodeficiency virus in the body (1995) (0)
Climate change and health. Authors reply [letter] (2006) (0)
Human population size, environment and health (2003) (0)
Diagnosis of inflammatory demyelination in biopsy specimens : a . A Practical Approach (2014) (0)
THE ALPHA-2 DOMAIN OF COMMON HLA B ALLELES DETERMINES A FAST OR SLOW ASSEMBLY PHENOTYPE (1993) (0)
Managing Our Environmental (2000) (0)
Late escape from an immunodominant cytotoxic T lymphocyte response associated with progression to AIDS (1997) (0)
4.1-01 Human trophoblast expresses a non classical HLA class I molecule (1989) (0)
T cell recognition of peptides bound to class I HLA molecules (1994) (0)
The use of tetramers in the quantitative analysis of T-cell responses (2002) (0)
Peer review correspondence (2014) (0)
A dose of reality: Changing Planet, Changing Health (Review) (2011) (0)
The influence of T lymphocytes on B-cell suppression (1983) (0)
MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) FROM THE MALARIA PARASITE P. FALCIPARUM (1998) (0)
Corrigendum to 'Unusual antigen presentation offers new insight into HIV vaccine design' [Curr Opin Immunol 46 (2017) 75-81]. (2018) (0)
NK Cell Inhibition (2011) (0)
Regimen Vaccinia Virus Ankara Boost Vaccination Multiepitope Gene and DNA Prime-Modified T Lymphocytes in Macaques by Using a Immunodeficiency Virus-Specific Cytotoxic Effective Induction of Simian (1999) (0)
Immune escape through T cell antagonism (1996) (0)
Climate change will affect public health -- a call to action (2008) (0)
Direct visualisation of hepatitis B virus (HBV)-specific cytotoxic T cells with an human leucocyte antigen (HLA) class I peptide tetrameric complex allows a new insight into their actual frequency. (1998) (0)
Phytoestrogen intake and plasma concentrations in South Asian and British women resident in the United Kingdom (2005) (0)
Methods and reagents for production of a CD8 + T cell immune response (1998) (0)
Preparing for HIV vaccines that induce cytotoxic T lymphocytes. (1998) (0)
AUSTRALIAN SYMPOSIUM ON NUTRITION AND CANCER (1979) (0)
An analysis of the events involved in the differentiation of naive CD8+T cells during a primary immune response in vivo (2005) (0)
A strongly selected mutation in the HIV-1 genome is independent of T cell responses and neutralizing antibodies (2017) (0)
Mount Gambier drinking water and birth defects. A laboratory study in rats after earlier epidemiological findings. (1984) (0)
Lung immunology in AIDS patients (1997) (0)
Collaboration in the revolution (1985) (0)
P20-17. Evolution of multiple transmitted viruses during the early stage of HIV-1 infection (2009) (0)
Environment, climate change, social factors and implications for infectious diseases (2012) (0)
B*57-Restricted Immune Response in HIV-1 Cross-Reactivity Characterize a Strong TCR Conservation and Altered T Cell (2017) (0)
Differential processing of an influenza nucleoprotein epitope in human and murine cells (1997) (0)
Molecular defence (1985) (0)
A Pilot Study of the Safety and Inununogenicity of An HIV-1 Clade a Gag/Multiepitope DNA Vaccine, pTHr.HIVA, in HIV-1 Seropositive Subjects Receiving Highly Active Antiretroviral Therapy (2003) (0)
Carriers Cells Specific for EBV in Healthy Virus T + A Re-Evaluation of the Frequency of CD 8 (1999) (0)
The genetics of HIV resistance in exposed uninfected Haemophilia A patients: an update on the CHAVI 014 protocol (2010) (0)
Global Environmental Hazards (2011) (0)
The impacts of global environmental change on human health: Extending the Sustainability Agenda (2001) (0)
HLA-B27 SUBTYPING BY SINGLE-STRAND CONFORMATION POLYMORPHISMS (SSCP) IN CAUCASOIDS, NEGROIDS AND INUITS FROM GREENLAND (1992) (0)
InfectionDistinguishes HIV-2 from HIV-1 T Cell + Maintenance of HIV-Specific CD4 (2017) (0)
Understanding the precursor frequencies of HIV-1 specific CD4+ T cells in seronegative donors (2012) (0)
Letter: Occupational mortality studies. (1976) (0)
CD4+ T follicular helper (Tfh) cells in human tonsil and blood are clonally convergent, but divergent from non-Tfh CD4+ cells (2019) (0)
Author Correction: Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding (2018) (0)
Investigation of the role of pregnancy and exposure to biological children in the onset of central nervous system demyelination (2010) (0)
The HIVconsv Vaccines Induce Polyfunctional and Highly Proliferative T Cells that Control In Vitro HIV Replication: HIV-CORE002 Phase-I Clinical Trial (2013) (0)
Life style and life course (2001) (0)
Comment on clinical development of candidate HIV vaccines: different problems for different vaccines. (2014) (0)
Role of class I molecules of the major histocompatibility complex in cytotoxic T-cell function in health and disease (2004) (0)
Activation Monocytes in a Reciprocal Program of Inflammatory Sites and Can Engage with NK Cells Are Enriched atbrightCD 56 (2004) (0)
P08-05. Does increased expression of HLA-C allow better control of HIV-1 viral load? (2009) (0)
IMPACT OF CLIMATE VARIABILITY ON TRANSMISSION OF EPIDEMIC POLYARTHRITIS (1998) (0)
Kinetics of the HBV-specific CTL response (1999) (0)
P16-13. A greater breadth of HIV-1-specific T cell responses detected using mosaic peptides compare to consensus peptides (2009) (0)
New in antigen-specif ic immunotherapies Novel therapeutic vaccines offer hope in the f ight against chronic infectious disease and cancer (2003) (0)
WS / PP-006-08 Apoptotic cells activate natural killer T cells through TIM-1 resulting in the induction of airway hyperreactivity (2010) (0)
The HIV-1 protective -35SNP effect in Caucasians is CD8 T cell mediated (2012) (0)
Death Ligand TRAIL New Receptor Protecting Lymphocytes from the ( TNF-Related Apoptosis-Inducing Ligand ) : A Cutting Edge : Lymphocyte Inhibitor of TRAIL Screaton (1997) (0)
Monocytes in a Reciprocal Program of Inflammatory Sites and Can Engage with NK Cells Are Enriched at bright CD56 (2017) (0)
HLA-reactive T cell clones: analysis of specificity. (1987) (0)
Environmental Change, Climate and Health: Plate section (2002) (0)
EXPOSURE ASSESSMENT FOR PREDICTIONS OF THE MORTALITY IMPACT OF CLIMATE IN 2030 IN AUSTRALIAN CITIES (1998) (0)
Characterising the role of dendritic cells (DCs') in the immunopathology of sarcoidosis (2001) (0)
Looking forward to better health: the view from the Better Health Commission. (1987) (0)
Identification and Characterisation of Derp1-Specific CD8+ T Cells in the Peripheral Blood of Atopic Individuals (2002) (0)
PHENOTYPIC CHARACTERIZATION OF NATURAL KILLER CELLS AND RECEPTORS IN SPONDYLOARTHRITIS (2004) (0)
INTERACTION BETWEEN INFLUENZA-VIRUS AND HLA ANTIGENS (1981) (0)
Immune Escape in Hiv Infection (1995) (0)
Control of Monocyte Numbers by Invariant Involvement of the 4-1BB/4-1BBL Pathway in (0)
Norman Letvin 1949–2012 (2012) (0)

This paper list is powered by the following services:

Other Resources About Andrew McMichael

en.wikipedia.org

What Schools Are Affiliated With Andrew McMichael?

Andrew McMichael is affiliated with the following schools:

Andrew McMichael's Academic­Influence.com Rankings